The neurology of mTOR

Area of Science:

• Neuroscience
• Cellular Biology
• Biochemistry

Background:

• The mechanistic target of rapamycin (mTOR) pathway is a central regulator of cell growth, metabolism, and protein synthesis.
• mTOR signaling is vital for normal brain function, integrating internal and external cellular cues.
• Dysfunction in the mTOR pathway is implicated in various neurological conditions, including autism, epilepsy, and neurodegenerative diseases.

Purpose of the Study:

• To review the multifaceted roles of mTOR signaling in both healthy and diseased brain states.
• To highlight the therapeutic potential of targeting the mTOR pathway for neurological disorders.
• To bridge the gap between understanding cellular physiology and developing clinical treatments.

Main Methods:

• Literature review of studies on mTOR signaling in the brain.
• Analysis of the involvement of mTOR in neurological disease pathogenesis.
• Examination of current and emerging therapeutic strategies targeting mTOR.

Main Results:

• mTOR pathway dysfunction is a common feature across a spectrum of neurological disorders.
• Pharmacological modulation of mTOR shows promise as a therapeutic approach.
• Clinical trials are underway for several mTOR-related neurological conditions.

Conclusions:

• The mTOR pathway is a critical nexus for brain function and a significant contributor to neurological pathology.
• Targeting mTOR represents a promising therapeutic avenue for treating a range of brain disorders.
• Translational research efforts are actively working to convert mechanistic insights into effective patient treatments.